Beijing BIOOCUS Biotech Ltd. is a pioneering company in the field of TIL-Based Immunotherapy. Our company is dedicated to developing innovative cancer treatments using TIL (tumor-infiltrating lymphocyte) technology. TIL-Based Immunotherapy involves extracting TILs from a patient's tumor, expanding and activating them in a laboratory, and then reintroducing them into the patient to target and destroy cancer cells, At Beijing BIOOCUS Biotech Ltd., we are committed to advancing the field of TIL-Based Immunotherapy and bringing innovative treatments to patients in need. With TIL-1, we aim to make a meaningful impact in the fight against cancer and improve outcomes for patients worldwide
Please feel free to give your inquiry in the form below We will reply you in 24 hours